A Multicenter,Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects With Epilepsy
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Diazepam (Primary)
- Indications Seizures
- Focus Pharmacokinetics
- Sponsors Aquestive Therapeutics
- 18 Dec 2017 Planned End Date changed from 24 Feb 2018 to 24 May 2018.
- 18 Dec 2017 Planned primary completion date changed from 31 Dec 2017 to 31 Mar 2018.
- 30 Nov 2017 According to an Aquestive Therapeutics media release, MonoSol Rx changed its name to Aquestive Therapeutics